JAKUB TOLAR to Administration, Intravenous
This is a "connection" page, showing publications JAKUB TOLAR has written about Administration, Intravenous.
Connection Strength
0.072
-
Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes. Sci Rep. 2019 Oct 01; 9(1):14105.
Score: 0.036
-
Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation. Pediatr Res. 2020 01; 87(1):104-111.
Score: 0.036